Sha Shi

402 total citations
21 papers, 279 citations indexed

About

Sha Shi is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Sha Shi has authored 21 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in Sha Shi's work include MicroRNA in disease regulation (4 papers), Estrogen and related hormone effects (4 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Sha Shi is often cited by papers focused on MicroRNA in disease regulation (4 papers), Estrogen and related hormone effects (4 papers) and Effects and risks of endocrine disrupting chemicals (3 papers). Sha Shi collaborates with scholars based in China and United States. Sha Shi's co-authors include Yuee Teng, Kezuo Hou, Lu Xu, Xiujuan Qu, Xiaofang Che, Yunpeng Liu, Zhi Li, Ti Wen, Lu Zhou and Jing Feng and has published in prestigious journals such as The Science of The Total Environment, Journal of Hazardous Materials and Brain Research.

In The Last Decade

Sha Shi

20 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sha Shi China 11 190 94 56 35 29 21 279
Yutong Meng China 9 236 1.2× 123 1.3× 49 0.9× 68 1.9× 40 1.4× 13 368
Ohuod Hawsawi United States 8 217 1.1× 132 1.4× 63 1.1× 85 2.4× 18 0.6× 10 330
Fumihiro Ishikawa Japan 10 174 0.9× 54 0.6× 44 0.8× 34 1.0× 27 0.9× 21 286
Gabriela Reyes‐Castellanos France 6 162 0.9× 134 1.4× 98 1.8× 21 0.6× 20 0.7× 10 257
Zhiwei Chen China 11 294 1.5× 128 1.4× 110 2.0× 34 1.0× 41 1.4× 24 404
Yifan Zeng China 8 277 1.5× 142 1.5× 73 1.3× 36 1.0× 26 0.9× 17 377
Nicola Currey Australia 9 207 1.1× 85 0.9× 77 1.4× 40 1.1× 27 0.9× 15 293
Quanfu Huang China 11 169 0.9× 101 1.1× 108 1.9× 88 2.5× 31 1.1× 20 346
Sang‐Seok Oh South Korea 13 203 1.1× 52 0.6× 61 1.1× 37 1.1× 47 1.6× 18 320

Countries citing papers authored by Sha Shi

Since Specialization
Citations

This map shows the geographic impact of Sha Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sha Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sha Shi more than expected).

Fields of papers citing papers by Sha Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sha Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sha Shi. The network helps show where Sha Shi may publish in the future.

Co-authorship network of co-authors of Sha Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Sha Shi. A scholar is included among the top collaborators of Sha Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sha Shi. Sha Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Sha, Wei Zheng, Ye Cheng, et al.. (2025). Estrogenic and transgenerational effects of perfluorocarboxylic acids through estrogen-related receptor γ pathway. Journal of Hazardous Materials. 495. 138994–138994. 2 indexed citations
2.
Shi, Sha, Chengkai Zhu, Shenyin Zhu, et al.. (2025). Tamoxifen regulates ferroptosis of hepatocytes by targeting SLC1A5 to activate hepatic stellate cells and liver fibrosis. Chemico-Biological Interactions. 418. 111586–111586.
3.
Shi, Sha, Jianming Jiang, Hui Liu, et al.. (2025). Neonicotinoid Insecticides in the Qiantang River: Occurrence, Sources, and Ecological Risks for Sustainable Water Resources. Sustainability. 17(2). 697–697. 1 indexed citations
4.
Xu, Lu, Sha Shi, Xin Li, et al.. (2024). Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189187–189187. 13 indexed citations
5.
Li, Fangfang, Lu Chen, Sha Shi, et al.. (2024). Perfluorobutanoic acid: A short-chain perfluoroalkyl substance exhibiting estrogenic effects through the estrogen-related receptor γ pathways. Journal of Hazardous Materials. 485. 136947–136947. 1 indexed citations
6.
Chen, Lu, Sha Shi, Minjie Li, et al.. (2023). Activation of estrogen-related receptor: An alternative mechanism of hexafluoropropylene oxide homologs estrogenic effects. The Science of The Total Environment. 901. 166257–166257. 16 indexed citations
7.
Xu, Lu, Jinglei Qu, Na Song, et al.. (2021). FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis. Annals of Translational Medicine. 9(3). 258–258. 17 indexed citations
8.
Xu, Lu, Jing Shi, Lei Zhao, et al.. (2020). Prognostic Value and Influence of Receptor Conversion on Treatment Regimen in Metastatic Breast Cancer at the First Time of Recurrence. Oncology Research and Treatment. 43(11). 620–627. 6 indexed citations
9.
10.
Xing, Xin, Ti Wen, Mingming Deng, et al.. (2020). Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer. Frontiers in Oncology. 10. 425–425. 24 indexed citations
11.
Xu, Lu, Lijie He, Jin Wang, et al.. (2020). MiR-891a-5p as a prognostic marker and therapeutic target for hormone receptor-positive breast cancer. Journal of Cancer. 11(13). 3771–3782. 20 indexed citations
12.
Liu, Chang, Zhi Li, Lu Xu, et al.. (2020). GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M. Aging. 12(12). 11794–11811. 30 indexed citations
13.
Xu, Lu, Jinglei Qu, Na Song, et al.. (2020). Biological and clinical significance of flap endonuclease‑1 in triple‑negative breast cancer: Support of metastasis and a poor prognosis. Oncology Reports. 44(6). 2443–2454. 12 indexed citations
14.
Zeng, Xue, Xiujuan Qu, Chenyang Zhao, et al.. (2019). FEN1 mediates miR‐200a methylation and promotes breast cancer cell growth via MET and EGFR signaling. The FASEB Journal. 33(10). 10717–10730. 38 indexed citations
15.
Li, Wěi, Ling Xu, Xiaofang Che, et al.. (2018). C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells. BMC Cancer. 18(1). 507–507. 10 indexed citations
16.
Shi, Sha, et al.. (2017). Pyogenic Granuloma of the Esophagus. Clinical Gastroenterology and Hepatology. 15(12). e177–e178. 4 indexed citations
17.
18.
Shi, Sha, et al.. (2017). Erlotinib in combination with bevacizumab and FOLFOX4 as second-line chemotherapy for patients with metastatic colorectal cancer.. PubMed. 7(9). 1971–1977. 7 indexed citations
19.
Shi, Sha, Han Wang, Hui Gao, et al.. (2014). Increased Gap Density Predicts Weakness of the Epithelial Barrier In Vivo by Confocal Laser Endomicroscopy in Indomethacin-Induced Enteropathy. Digestive Diseases and Sciences. 59(7). 1398–1405. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yutong Meng Breakdown of academic impact, for papers by Ohuod Hawsawi Breakdown of academic impact, for papers by Fumihiro Ishikawa Breakdown of academic impact, for papers by Gabriela Reyes‐Castellanos Breakdown of academic impact, for papers by Zhiwei Chen Breakdown of academic impact, for papers by Yifan Zeng Breakdown of academic impact, for papers by Nicola Currey Breakdown of academic impact, for papers by Quanfu Huang Breakdown of academic impact, for papers by Sang‐Seok Oh
Rankless by CCL
2026